MASH is an advanced stage of metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver ... to collect a small sample of tissue.

A deeper understanding of a gene that predisposes patients to fatty liver disease may open new avenues for treatment of the ...

More than 30% of people worldwide have metabolic dysfunction–associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver ... this study had a small sample size of 24 patients.

This was accompanied by histological and gene expression analysis of adipose tissue and ... Plasma and liver triglycerides, cholesterol and non-esterified free fatty acids were determined via ...